BioNTech may be at least 32 times less effective in handling the new Omicron variant, a new study has found. Photo: May Tse
BioNTech may be at least 32 times less effective in handling the new Omicron variant, a new study has found. Photo: May Tse

Coronavirus: BioNTech vaccine could be much less effective against Omicron, Hong Kong research team finds

  • Inoculation remains only effective way to protect against Covid-19, university researchers say, urging elderly and other high-risk groups to get booster shots
  • Little known so far about new variant’s severity, though early data from South Africa shows low rate of hospitalisation

Topic |   Coronavirus pandemic
BioNTech may be at least 32 times less effective in handling the new Omicron variant, a new study has found. Photo: May Tse
BioNTech may be at least 32 times less effective in handling the new Omicron variant, a new study has found. Photo: May Tse
READ FULL ARTICLE